On ECHEMI
Home > Drugs > Zhengzhou Ruikang Pharmaceutical Co., Ltd.
Zhengzhou Ruikang Pharmaceutical Co., Ltd.
  • Founded in:

    1994-06-26
  • Country:

    China China
  • Address:

    No. 84, Ruida Road, Zhengzhou High-tech Industrial Development Zone
  • Tax NO.:

    914101001700481114
  • Registered Funds:

    65.294103 yuan
  • Website:

  • Email:

Related Drugs
Lomefloxacin hydrochloride
Name Description Content CAS NO. Registered Holders
Lomefloxacin hydrochloride

Not clearly described

More

Not clearly described

98079-52-8 12
Famotidine
Famotidine.
Name Description Content CAS NO. Registered Holders
Famotidine

It has a significant inhibitory effect on gastric acid secretion and can also inhibit the secretion of pepsin

More

It has a significant inhibitory effect on gastric acid secretion and can also inhibit the secretion of pepsin

76824-35-6 69
Nimodipine
Name Description Content CAS NO. Registered Holders
Nimodipine

The specific pharmacological effects are not clearly described from the above information

More

The specific pharmacological effects are not clearly described from the above information

66085-59-4 17
Fleroxacin
The main ingredient of this product is fleroxacin, whose chemical name is 6,8-difluoro-1-(2-fluoroethyl)1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid.
Name Description Content CAS NO. Registered Holders
Fleroxacin

This product is a quinolone antibacterial drug, which has strong antibacterial effect on Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Proteus, Salmonella typhi, Salmonella paratyphi, Shigella, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter, Serratia marcescens, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae, Moracata, Legionella pneumophila, Neisseria gonorrhoeae, etc. It also has moderate antibacterial effect on Gram-positive cocci such as Staphylococcus and hemolytic Streptococcus. The mechanism of action of this product is to inhibit the bacterial DNA gyrase and thus kill bacteria.

More

This product is a quinolone antibacterial drug, which has strong antibacterial effect on Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Proteus, Salmonella typhi, Salmonella paratyphi, Shigella, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter, Serratia marcescens, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae, Moracata, Legionella pneumophila, Neisseria gonorrhoeae, etc. It also has moderate antibacterial effect on Gram-positive cocci such as Staphylococcus and hemolytic Streptococcus. The mechanism of action of this product is to inhibit the bacterial DNA gyrase and thus kill bacteria.

79660-72-3 6
Nimodipine Tablets
1,4-Dihydropyridines
Name Description Content CAS NO. Registered Holders
Nimodipine

1,4-dihydropyridine calcium channel blockers can effectively regulate the level of intracellular calcium, prevent and treat ischemic damage to brain tissue caused by cerebral vasospasm due to subarachnoid hemorrhage, inhibit the influx of extracellular calcium ions into vascular smooth muscle cells, dilate cerebral blood vessels, and have almost no effect on peripheral blood vessels. Increasing the dose also has a good therapeutic effect on hypertension.

More

1,4-dihydropyridine calcium channel blockers can effectively regulate the level of intracellular calcium, prevent and treat ischemic damage to brain tissue caused by cerebral vasospasm due to subarachnoid hemorrhage, inhibit the influx of extracellular calcium ions into vascular smooth muscle cells, dilate cerebral blood vessels, and have almost no effect on peripheral blood vessels. Increasing the dose also has a good therapeutic effect on hypertension.

66085-59-4 17
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.